Skip to main content
PolicySpeak
← All files
ESS

EssilorLuxottica

Company · Italy

2
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
2
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track EssilorLuxottica in PolicySpeak: request access →

Work at EssilorLuxottica? so we know who speaks for it.

Follow the files EssilorLuxottica engages with

One email on Tuesdays when a new position is filed on these 2 files, from EssilorLuxottica or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

EssilorLuxottica filed 2 positions between 3 Sept 2025 and 31 Jul 2026, across 2 of the 326 legislative files tracked here, attaching a full position paper 2 times.

2025 · 1 filed2026 · 1 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 31 Jul 2026PDFsource

EssilorLuxottica welcomes the European Commission's initiative to modernize the regulatory framework for medical devices and encourages the inclusion of provisions enabling electronic Instructions for Use (e-IFU) as the default information format for eligible Class I and Class II medical devices intended for lay users.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Is this your organization?

Everything on this page comes from EssilorLuxottica’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.